Serena Guiducci
Overview
Explore the profile of Serena Guiducci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
238
Citations
5905
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ariani A, Bedogni G, Biasi G, Cozzi F, Formisano S, Gorla R, et al.
Int J Biometeorol
. 2025 Mar;
PMID: 40044963
Balneotherapy (BT) is considered an effective, non-pharmacological approach, in the multimodal treatment of the Primary Fibromyalgia Syndrome (FS). However, the evidence of efficacy and tolerability of BT in FS is...
2.
Guiducci S, Bagni M, Torracchi S, Bernardini P, Maresca M, Vanini L, et al.
J Ultrasound
. 2025 Feb;
PMID: 40011390
Purpose: To evaluate the use of ultrasound (US) in identifying the inflammatory or not inflammatory changes in different diseases that involve the temporomandibular joint (TMJ). Methods: 165 patients [50 Rheumatoid...
3.
Ferraioli M, Levani J, De Luca R, Matucci-Cerinic C, Gattorno M, Guiducci S, et al.
J Clin Med
. 2025 Feb;
14(4).
PMID: 40004896
Synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome is a rare disease characterized by a sterile inflammatory osteitis and/or arthritis associated with a wide range of dermatological manifestations, such as acne, palmoplantar pustulosis, and psoriasis....
4.
Baldi C, Gentileschi S, Li Gobbi F, Cazzato M, Delle Sedie A, Gaggiano C, et al.
Clin Exp Med
. 2025 Feb;
25(1):50.
PMID: 39909970
This study evaluates upadacitinib (UPA) effectiveness and drug retention rate (DRR) in patients with rheumatoid arthritis (RA). Multicentre prospective observational study. Consecutive patients with RA receiving UPA were evaluated at...
5.
Cacciapaglia F, De Angelis R, Ferri C, Bajocchi G, Bellando-Randone S, Bruni C, et al.
J Rheumatol
. 2025 Jan;
PMID: 39814435
Objective: Bosentan (BOS) is approved for treating pulmonary arterial hypertension (PAH) and preventing digital ulcers (DU) in systemic sclerosis (SSc). Our study aimed to evaluate whether BOS prescribed for DU...
6.
Bonomi F, Bandini G, Guiducci S, Matucci-Cerinic M, Bellando Randone S
Rheumatology (Oxford)
. 2024 Dec;
PMID: 39724207
No abstract available.
7.
Romanazzo S, Rometsch C, Marangoni A, Guiducci S, Cosci F
Front Med (Lausanne)
. 2024 Dec;
11:1473587.
PMID: 39712185
Objectives: (a) Assessing mental disorders, psychological distress, psychological wellbeing in patients with systemic sclerosis (SSc); (b) identifying psychological features independently contributing to the status of having the diagnosis of SSc....
8.
Sebastiani M, Lepri G, Iannone C, Bozzalla Cassione E, Guggino G, Lo Monaco A, et al.
J Rheumatol
. 2024 Dec;
PMID: 39681380
Objective: Some concerns remain about the safety of nintedanib in patients with rheumatoid arthritis-related interstitial lung disease (RA-ILD), such as in the presence of comorbidities or in combination with biologic,...
9.
Gentileschi S, Bruni C, Gaggiano C, DAlessandro R, Pacini G, Sota J, et al.
Ther Adv Musculoskelet Dis
. 2024 Nov;
16:1759720X241292312.
PMID: 39610981
Background: Real-world evidence supporting a safe and effective transition from rituximab originator (RTX-O) to its biosimilars (RTX-B) in autoimmune rheumatic diseases (ARDs) is still limited. Objectives: The primary aims of...
10.
Gentileschi S, Cannistra C, Gaggiano C, Damiani A, Carli L, Benucci M, et al.
J Pers Med
. 2024 Nov;
14(11).
PMID: 39590597
Background: This study aimed to evaluate the effectiveness and drug retention rate of secukinumab (SCK) in axial spondyloarthritis (ax-SpA) within a multicentric real-life cohort. Methods: Data from patients with ax-SpA...